Nutraceuticals for older people: Facts, fictions and gaps in knowledge

Maturitas

Volumn 75, Issue 4, 2013, Pages 313-334

  González Sarrías, Antonio ^a   Larrosa, Mar ^a   García Conesa, María Teresa ^a   Tomás Barberán, Francisco A ^a   Espín, Juan Carlos ^a  

^a RESEARCH GROUP ON QUALITY   (Spain)

Author keywords

Age related diseases; Clinical trials; Elderly; Health claims; Nutraceuticals

Indexed keywords

ASCORBIC ACID; BETA CAROTENE; CALCITONIN; CATECHIN; COLECALCIFEROL; CURCUMIN; DIMETHYL SULFONE; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; GENISTEIN; GINGER EXTRACT; GLUCOSAMINE SULFATE; GREEN TEA EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MINERAL; NONSTEROID ANTIINFLAMMATORY AGENT; NUTRACEUTICAL; POLYPHENOL; POLYPHENON E; PROBIOTIC AGENT; RESVERATROL; SALCATONIN; STANOL ESTER; STANOZOLOL; UBIQUINONE; UNINDEXED DRUG; ZEAXANTHIN;

ANTINEOPLASTIC ACTIVITY; ARTHRITIS; BONE DENSITY; BRAIN DISEASE; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATARACT; CHOLESTEROL BLOOD LEVEL; COLORECTAL CANCER; DIET SUPPLEMENTATION; DIETARY FIBER; DRUG MARKETING; FOLLOW UP; HUMAN; METABOLIC DISORDER; OSTEOCLAST ACTIVITY; OSTEOLYSIS; OSTEOPOROSIS; PROSTATE CANCER; REVIEW; RISK REDUCTION; TREATMENT DURATION; TUMOR CELL; AGED; ANIMAL; DRUG LABELING; EVIDENCE BASED MEDICINE; HEALTH;

ANIMALIA;

AGED; ANIMALS; DIETARY SUPPLEMENTS; DRUG LABELING; EVIDENCE-BASED MEDICINE; HEALTH; HUMANS;

EID: 84880263968     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2013.05.006     Document Type: Review

References (312)

1. P.B. Yu, and H.Y. Chung The inflammatory process in ageing Review in Clinical Gerontology 16 2006 179 187
2. E. Diczfalusy The demographic revolution and our common future Maturitas 38 2001 5 14
3. T.R. Fried, E.H. Bradley, C.S. Williams, and M.E. Tinetti Functional disability and health care expenditures for older persons Archives of Internal Medicine 161 2001 2602 2607
4. S.A. Talegawkar, S. Bandinelli, and K. Bandeen-Roche A higher adherence to a Mediterranean-style diet is inversely associated with the development of frailty in community-dwelling elderly men and women The Journal of Nutrition 142 2012 2161 2166
5. R.L. Bailey, J.J. Gahche, and C.V. Lentino Dietary supplement use in the United States, 2003-2006 The Journal of Nutrition 141 2011 261 266
6. G. Skeie, T. Braaten, and A. Hjartaker Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study European Journal of Clinical Nutrition 63 2009 S226 S238
7. M.A. Rovira, M. Grau, O. Castañer, M.I. Covas, H. Schröder REGICOR Investigators Dietary supplement use and health-related behaviors in a mediterranean population Journal of Nutrition Education and Behavior 2012 pii: S1499-4046(12)00076-0
8. S. De Felice The nutraceutical revolution: fueling a powerful, new international market 1989 www.fimdefelice.org.
9. S.H. Zeisel Regulation of "nutraceuticals" Science 285 1999 1853 1855
10. European Food Safety Authority Compendium of botanicals reported to contain naturally occuring substances of possible concern for human health when used in food and food supplements EFSA Journal 10 5 2012 2663 [60 pp.]
11. G. Buhr, and C.W. Bales Nutritional supplements for older adults: review and recommendations-part I Journal of Nutrition for the Elderly 28 2009 5 29
12. G. Buhr, and C.W. Bales Nutritional supplements for older adults: review and recommendations - Part II Journal of Nutrition for the Elderly 29 2010 42 71
13. D. Albanes, N. Malila, and P.R. Taylor Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland) Cancer Causes & Control: CCC 11 2000 197 205 (Pubitemid 30182136)
14. J. Virtamo, B.K. Edwards, and M. Virtanen Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland) Cancer Causes & Control: CCC 11 2000 933 939 (Pubitemid 32005305)
15. J.M. Gaziano, R.J. Glynn, and W.G. Christen Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial JAMA: the Journal of the American Medical Association 301 2009 52 62
16. E. Lonn, J. Bosch, and S. Yusuf Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial JAMA: the Journal of the American Medical Association 293 2005 1338 1347 (Pubitemid 40381486)
17. S.M. Lippman, E.A. Klein, and P.J. Goodman Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) JAMA: the Journal of the American Medical Association 301 2009 39 51
18. A. Avenell, G.S. MacLennan, and D.J. Jenkinson Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial) The Journal of Clinical Endocrinology and Metabolism 97 2012 614 622
19. S.T. Mayne, B. Cartmel, and M. Baum Randomized trial of supplemental beta-carotene to prevent second head and neck cancer Cancer Research 61 2001 1457 1463 (Pubitemid 34292573)
20. T.E. Moon, N. Levine, and B. Cartmel Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 6 1997 949 956 (Pubitemid 27481644)
21. R. Jaszewski, S. Misra, and M. Tobi Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial World Journal of Gastroenterology 14 2008 4492 4498
22. B.F. Cole, J.A. Baron, and R.S. Sandler Folic acid for the prevention of colorectal adenomas: a randomized clinical trial JAMA: the Journal of the American Medical Association 297 2007 2351 2359 (Pubitemid 46883748)
23. K. Wu, E.A. Platz, and W.C. Willett A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma The American Journal of Clinical Nutrition 90 2009 1623 1631
24. S.M. Zhang, N.R. Cook, C.M. Albert, J.M. Gaziano, J.E. Buring, and J.E. Manson Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial JAMA: the Journal of the American Medical Association 300 2008 2012 2021
25. N.R. Cook, C.M. Albert, and J.M. Gaziano A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study Archives of Internal Medicine 167 2007 1610 1618 (Pubitemid 47280341)
26. J. Hsia, G. Heiss, and H. Ren Calcium/vitamin D supplementation and cardiovascular events Circulation 115 2007 846 854 (Pubitemid 46294725)
27. G. Saposnik, J.G. Ray, P. Sheridan, M. McQueen, E. Lonn Heart Outcomes Prevention Evaluation 2 Investigators Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial Stroke 40 2009 1365 1372
28. N. Khandanpour, M.P. Armon, and B. Jennings Randomized clinical trial of folate supplementation in patients with peripheral arterial disease The British Journal of Surgery 96 2009 990 998
29. H.N. Hodis, J.M. Wendy, and L. Dustin High- dose B-vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial Stroke 40 2009 730 736
30. The VITATOPS Trial Study Group B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial Lancet 9 2010 855 865
31. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group J.M. Armitage, and L. Bowman Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial JAMA: the Journal of the American Medical Association 303 2010 2486 2494
32. C.M. Albert, N.R. Cook, and J.M. Gaziano Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial JAMA: the Journal of the American Medical Association 299 2008 2027 2036 (Pubitemid 351656584)
33. F. Szabo de Edelenyi, A.C. Vergnaud, and N. Ahluwalia Effect of B-vitamins and n-3 PUFA supplementation for 5 years on blood pressure in patients with CVD The British Journal of Nutrition 107 2012 921 927
34. P. Galan, E. Kesse-Guyot, and S. Czernichow Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial British Medical Journal 341 2010 c6273
35. K. Gopinath, and D. Danda Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial International Journal of Rheumatic Diseases 14 2011 332 339
36. T. McAlindon, M. LaValley, and E. Schneider Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial JAMA: the Journal of the American Medical Association 309 2013 155 162
37. L.M. Buckley, E.S. Leib, K.S. Cartularo, P.M. Vacek, and S.M. Cooper Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial Annals of Internal Medicine 125 1996 961 968
38. E.W. Karlson, N.A. Shadick, N.R. Cook, J.E. Buring, and I.M. Lee Vitamin E in the primary prevention of rheumatoid arthritis: the Women's Health Study Arthritis and Rheumatism 59 2008 1589 1595
39. A.E. van Ede, R.F. Laan, and M.J. Rood Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study Arthritis and Rheumatism 44 2001 1515 1524 (Pubitemid 32651731)
40. J.B. Shiroky, C. Neville, and J.M. Esdaile Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial Arthritis and Rheumatism 36 1993 795 803 (Pubitemid 23175621)
41. S.L. Morgan, J.E. Baggott, J.Y. Lee, and G.S. Alarcón Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention The Journal of Rheumatology 25 1998 441 446 (Pubitemid 28109342)
42. W.B. Jonas, C.P. Rapoza, and W.F. Blair The effect of niacinamide on osteoarthritis: a pilot study Inflammation Research: Official Journal of the European Histamine Research Society 45 1996 330 334 (Pubitemid 26245650)
43. M.A. Flynn, W. Irvin, and G. Krause The effect of folate and cobalamin on osteoarthritic hands Journal of the American College of Nutrition 13 1994 351 356 (Pubitemid 24251142)
44. M. Chung, E.M. Balk, and M. Brendel Vitamin D and calcium: a systematic review of health outcomes Evidence Report/Technology Assessment 183 2009 1 420
45. D.A. Hanley, A. Cranney, and G. Jones Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada CMAJ: Canadian Medical Association Journal 182 2010 E610 E618
46. United States Food and Drug Administration Guidance for Industry. Food Labeling: Health Claims; Calcium and Osteoporosis, and Calcium, Vitamin D, and Osteoporosis. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/ GuidanceDocuments/FoodLabelingNutrition/ucm152626.htm.
47. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific opinion on the substantiation of health claims related to vitamin D and maintenance of bone and teeth (ID 150, 151, 158), absorption and utilisation of calcium and phosphorus and maintenance of normal blood calcium concentrations (ID 152, 157), cell division (ID 153), and thyroid function (ID 156) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 on request from the European Commission EFSA Journal 7 9 2009 1227 [19 pp.]
48. R.L. Wolf, J.A. Cauley, and M. Pettinger Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women's Health Initiative The American Journal of Clinical Nutrition 3 2005 581 588
49. V.S. Talaulikar, T. Chambers, and I. Manyonda Exploiting the antioxidant potential of a common vitamin: could vitamin C prevent postmenopausal osteoporosis? The Journal of Obstetrics and Gynaecology Research 38 2012 253 257
50. M. Ruiz-Ramos, L.A. Vargas, T.I. Fortoul Van der Goes, A. Cervantes-Sandoval, and V.M. Mendoza-Nunez Supplementation of ascorbic acid and alpha-tocopherol is useful to preventing bone loss linked to oxidative stress in elderly The Journal of Nutrition, Health & Aging 14 2010 467 472
51. R.A. Dhonukshe-Rutten, S.M. Pluijm, L.C. de Groot, P. Lips, J.H. Smit, and W.A. van Staveren Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 20 2005 921 929 (Pubitemid 40712815)
52. C.G. Gjesdal, S.E. Vollset, P.M. Ueland, H. Refsum, H.E. Meyer, and G.S. Tell Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the hordaland homocysteine study Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 22 2007 747 756 (Pubitemid 351339104)
53. M. Herrmann, N. Umanskaya, and L. Traber The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial Clinical Chemistry and Laboratory Medicine: CCLM/FESCC 45 2007 1785 1792 (Pubitemid 350232977)
54. N. Binkley, J. Harke, and D. Krueger Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 24 2009 983 991
55. N. Koitaya, J. Ezaki, and M. Nishimuta Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women Journal of Nutritional Science and Vitaminology 55 2009 15 21
56. M.H. Knapen, L.J. Schurgers, and C. Vermeer Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 18 2007 963 972 (Pubitemid 46889558)
57. A.M. Cheung, L. Tile, and Y. Lee Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial PLoS Medicine 5 2008 e196
58. J.M. Teikari, M. Rautalahti, and J. Haukka Incidence of cataract operations in Finnish male smokers unaffected by alpha tocopherol or beta carotene supplements Journal of Epidemiology and Community Health 52 1998 468 472 (Pubitemid 28349717)
59. W. Christen, R. Glynn, R. Sperduto, E. Chew, and J. Buring Age-related cataract in a randomized trial of beta-carotene in women Ophthalmic Epidemiology 11 2004 401 412 (Pubitemid 40095933)
60. W.G. Christen, J.E. Manson, and R.J. Glynn A randomized trial of beta carotene and age-related cataract in US physicians Archives of Ophthalmology 121 2003 372 378 (Pubitemid 36298120)
61. S. Park, M. Johnson, and J.G. Fischer Vitamin and mineral supplements: barriers and challenges for older adults Journal of Nutrition for the Elderly 27 2008 297 317
62. L.C. Clark, G.F. Combs Jr., and B.W. Turnbull Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group JAMA: the Journal of the American Medical Association 276 1996 1957 1963 (Pubitemid 26427723)
63. M.E. Reid, A.J. Duffield-Lillico, A. Sunga, M. Fakih, D.S. Alberts, and J.R. Marshall Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial International Journal of Cancer 118 2006 1777 1781 (Pubitemid 43376443)
64. Y.L. Qiao, S.M. Dawsey, and F. Kamangar Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial Journal of the National Cancer Institute 101 2009 507 518
65. J.R. Marshall, C.M. Tangen, and W.A. Sakr Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917 Cancer Prevention Research 4 2011 1761 1769
66. E.A. Klein, I.M. Thompson Jr., and C.M. Tangen Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) JAMA: the Journal of the American Medical Association 306 2011 1549 1556
67. M.E. Goossens, F. Buntinx, and S. Joniau Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium BMC Urology 12 2012 8
68. S. Stranges, J.R. Marshall, and R. Natarajan Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial Annals of Internal Medicine 147 2007 217 223 (Pubitemid 351664577)
69. M.P. Rayman, G. Blundell-Pound, R. Pastor-Barriuso, E. Guallar, H. Steinbrenner, and S. Stranges A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin PLoS One 7 2012 e45269
70. V. Fedirko, R.M. Bostick, and Q. Long Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 19 2010 280 291
71. T.E. Rohan, A. Negassa, and R.T. Chlebowski A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease Breast Cancer Research and Treatment 116 2009 339 350
72. Z. Sabbagh, and H. Vatanparast Is calcium supplementation a risk factor for cardiovascular diseases in older women? Nutrition Reviews 67 2009 105 108
73. M.J. Bolland, P.A. Barber, and R.N. Doughty Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial British Medical Journal 336 2008 262 266 (Pubitemid 351251627)
74. B.M. Tang, G.D. Eslick, C. Nowson, C. Smith, and A. Bensoussan Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis Lancet 370 2007 657 666 (Pubitemid 47285316)
75. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific opinion on the substantiation of health claims related to calcium and growth, development and maintenance of the normal structure and function of bones and teeth (ID 224, 230, 231, 354, 3099), muscle function and neurotransmission (ID 226, 227, 230, 235), blood coagulation (ID 230, 236), energy-yielding metabolism (ID 234), normal function of digestive enzymes (ID 355), and maintenance of a normal blood pressure (ID 225, 385, 1419) pursuant to Article 13(1) of Regulation (EC) No 1924/2006on request from the European Commission EFSA Journal 7 9 2009 1210 [27 pp.]
76. D. Thiébaud, P. Burckhardt, and J. Melchior Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 4 1994 76 83 (Pubitemid 24103699)
77. C.D. Rubin, C.Y. Pak, B. Adams-Huet, H.K. Genant, J. Li, and D.S. Rao Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis Archives of Internal Medicine 161 2001 2325 2333 (Pubitemid 32980131)
78. J.D. Ringe, A. Dorst, C. Kipshoven, L.C. Rovati, and I. Setnikar Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 8 1998 47 52 (Pubitemid 28085484)
79. N. Guañabens, J. Farrerons, and L. Perez-Edo Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: a randomized 3 year trial Bone 27 2000 123 128 (Pubitemid 30365087)
80. D.H. Gutteridge, G.O. Stewart, and R.L. Prince A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 13 2002 158 170 (Pubitemid 34241036)
81. J.L. Sebert, P. Richard, I. Mennecier, J.P. Bisset, and G. Loeb Monofluorophosphate increases lumbar bone density in osteopenic patients: a double-masked randomized study Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 5 1995 108 114
82. P. Alexandersen, B.J. Riis, and C. Christiansen Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study The Journal of Clinical Endocrinology and Metabolism 84 1999 3013 3020 (Pubitemid 30646915)
83. T.M. Murray, and L.G. Ste-Marie Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 7. Fluoride therapy for osteoporosis CMAJ: Canadian Medical Association Journal 155 1996 949 954
84. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of health claims related to fluoride and maintenance of tooth mineralisation (ID 275, 276) and maintenance of bone (ID 371) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 on request from the European Commission EFSA Journal 7 9 2009 1212 [13 pp.]
85. M. Marangella, M. Di Stefano, S. Casalis, S. Berutti, P. D'Amelio, and G.C. Isaia Effects of potassium citrate supplementation on bone metabolism Calcified Tissue International 74 2004 330 335 (Pubitemid 38480856)
86. H.M. Macdonald, A.J. Black, and L. Aucott Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial The American Journal of Clinical Nutrition 88 2008 465 474
87. K.M. Ryder, R.I. Shorr, and A.J. Bush Magnesium intake from food and supplements is associated with bone mineral density in healthy older white subjects Journal of the American Geriatrics Society 53 2005 1875 1880 (Pubitemid 41826063)
88. J.E. Sojka, and C.M. Weaver Magnesium supplementation and osteoporosis Nutrition Reviews 53 1995 71 74
89. H. Aydin, O. Deyneli, and D. Yavuz Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women Biological Trace Element Research 133 2010 136 143
90. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and maintenance of normal cardiac function (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325), maintenance of normal blood glucose concentrations (ID 566), maintenance of normal blood pressure (ID 506, 516, 703, 1317, 1324), maintenance of normal blood HDL-cholesterol concentrations (ID 506), maintenance of normal (fasting) blood concentrations of triglycerides (ID 506, 527, 538, 1317, 1324, 1325), maintenance of normal blood LDL-cholesterol concentrations (ID 527, 538, 1317, 1325, 4689), protection of the skin from photo-oxidative (UV-induced) damage (ID530), improved absorption of EPA and DHA (ID 522, 523), contribution to the normal function of the immune system by decreasing the levels of eicosanoids, arachidonic acid-derived mediators and pro-inflammatory cytokines (ID 520, 2914), and "immunomodulating agent" (4690) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Journal 8 10 2010 1796 [32 pp.]
91. M. Yokoyama, H. Origasa, and M. Matsuzaki Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Lancet 369 2007 1090 1098 (Pubitemid 46483662)
92. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial Lancet 354 1999 447 455
93. R.J. Woodman, T.A. Mori, V. Burke, I.B. Puddey, G.F. Watts, and L.J. Beilin Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension The American Journal of Clinical Nutrition 76 2002 1007 1015 (Pubitemid 35244671)
94. H. Oe, T. Hozumi, and E. Murata Arachidonic acid and docosahexaenoic acid supplementation increases coronary flow velocity reserve in Japanese elderly individuals Heart 94 2008 316 321 (Pubitemid 351303423)
95. R.G. Metcalf, P. Sanders, M.J. James, L.G. Cleland, and G.D. Young Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy The American Journal of Cardiology 101 2008 758 761
96. Q. Wang, X. Liang, and L. Wang Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials Atherosclerosis 221 2012 536 543
97. E.C. Rizos, E.E. Ntzani, E. Bika, M.S. Kostapanos, and M.S. Elisaf Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis JAMA: the Journal of the American Medical Association 308 2012 1024 1033
98. K.B. Filion, F. El Khoury, M. Bielinski, I. Schiller, N. Dendukuri, and J.M. Brophy Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials BMC Cardiovascular Disorders 10 2010 24
99. A.J. Cockbain, G.J. Toogood, and M.A. Hull Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer Gut 61 2012 135 149
100. E.D. Courtney, S. Matthews, and C. Finlayson Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas International Journal of Colorectal Disease 22 2007 765 776 (Pubitemid 46863753)
101. R.I. Sperling, M. Weinblatt, and J.L. Robin Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis Arthritis and Rheumatism 30 1987 988 997 (Pubitemid 17149908)
102. J.M. Kremer, W. Jubiz, and A. Michalek Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study Annals of Internal Medicine 106 1987 497 503 (Pubitemid 17095031)
103. J.M. Kremer, D.A. Lawrence, and W. Jubiz Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects Arthritis and Rheumatism 33 1990 810 820 (Pubitemid 20205760)
104. G.L. Nielsen, K.L. Faarvang, and B.S. Thomsen The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial European Journal of Clinical Investigation 22 1992 687 691
105. P. Geusens, C. Wouters, J. Nijs, Y. Jiang, and J. Dequeker Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study Arthritis and Rheumatism 37 1994 824 829 (Pubitemid 24184532)
106. B. Galarraga, M. Ho, and H.M. Youssef Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis Rheumatology 47 2008 665 669 (Pubitemid 351619210)
107. Y. Park, A. Lee, and S.C. Shim Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea The Journal of Nutritional Biochemistry 2013 10.1016/j.jnutbio. 2012.11.004 pii:S0955-2863(12)00289-6
108. B. Tartibian, B. Hajizadeh Maleki, J. Kanaley, and K. Sadeghi Long-term aerobic exercise and omega-3 supplementation modulate osteoporosis through inflammatory mechanisms in post-menopausal women: a randomized, repeated measures study Nutrition and Metabolism 8 2011 71
109. P. Salari Sharif, M. Asalforoush, F. Ameri, B. Larijani, and M. Abdollahi The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial Age 32 2010 179 186
110. N. Ubeda, M. Achón, and G. Varela-Moreiras Omega 3 fatty acids in the elderly The British Journal of Nutrition 107 2012 S137 S151
111. Anon. Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and brain, eye and nerve development (ID 501, 513, 540), maintenance of normal brain function (ID 497, 501, 510, 513, 519, 521, 534, 540, 688, 1323, 1360, 4294), maintenance of normal vision (ID 508, 510, 513, 519, 529, 540, 688, 2905, 4294), maintenance of normal cardiac function (ID 510, 688, 1360), "maternal health; pregnancy and nursing" (ID 514), "to fulfil increased omega-3 fatty acids need during pregnancy" (ID 539), "skin and digestive tract epithelial cells maintenance" (ID 525), enhancement of mood (ID536), "membranes cell structure" (ID4295), "anti-inflammatory action" (ID 4688) and maintenance of normal blood LDL-cholesterol concentrations (ID4719) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Journal 9 4 2011 2078 [30 pp.]
112. J.M. Lattimer, and M.D. Haub Effects of dietary fiber and its components on metabolic health Nutrients 2 2010 1266 1289
113. S. Bingham The fibre-folate debate in colo-rectal cancer The Proceedings of the Nutrition Society 65 2006 19 23 (Pubitemid 43259980)
114. P.J. Limburg, M.R. Mahoney, and K.L.A. Ziegler Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention Cancer Prevention Research 4 2011 259 269
115. J.C. Mathers, M. Movahedi, and F. Macrae Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial The Lancet Oncology 13 2012 1242 1249
116. J.W. Anderson, P. Baird, and R.H. Davis Jr. Health benefits of dietary fiber Nutrition Reviews 67 2009 188 205
117. R. Estruch, M.A. Martínez-González, and D. Corella Effects of dietary fibre intake on risk factors for cardiovascular disease in subjects at high risk Journal of Epidemiology and Community Health 63 2009 582 588
118. R. Solà, E. Bruckert, and R.M. Valls Soluble fibre (Plantago ovata husk) reduces plasma low-density lipoprotein (LDL) cholesterol, triglycerides, insulin, oxidised LDL and systolic blood pressure in hypercholesterolaemic patients: a randomised trial Atherosclerosis 211 2010 630 637
119. M. de Vrese, and J. Schrezenmeir Probiotics, prebiotics, and synbiotics Advances in Biochemical Enginering/Biotechnology 111 2008 1 66
120. K. Kotzampassi, and E.J. Giamarellos-Bourboulis Probiotics for infectious diseases: more drugs, less dietary supplementation International Journal of Antimicrobial Agents 40 2012 288 296
121. G. Malaguarnera, F. Leggio, and M. Vacante Probiotics in the gastrointestinal diseases of the elderly The Journal of Nutrition, Health & Aging 16 2012 402 410
122. M.L. Ritchie, and T.N. Romanuk A meta-analysis of probiotic efficacy for gastrointestinal diseases PLoS One 7 2012 e34938
123. Z. Guo, X.M. Liu, and Q.X. Zhang Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 21 2011 844 850
124. Z. Liu, H. Qin, and Z. Yang Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study Alimentary Pharmacology & Therapeutics 33 2011 50 63
125. J.H. Stephens, and P.J. Hewett Clinical trial assessing VSL#3 for the treatment of anterior resection syndrome ANZ Journal of Surgery 82 2012 420 427
126. P. Pozzoni, A. Riva, and A.G. Bellatorre Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial The American Journal of Gastroenterology 107 2012 922 931
127. F. Tomás-Barberán, and J.C. Espín Phenolic compounds and related enzymes as determinants of quality in fruits and vegetables Journal of the Science of Food and Agriculture 81 2001 853 876 (Pubitemid 32652987)
128. C. Manach, A. Scalbert, C. Morand, C. Rémésy, and L. Jiménez Polyphenols: food source and bioavailability The American Journal of Clinical Nutrition 79 2004 727 747
129. I.C.W. Arts, and P.C.H. Hollman Polyphenols and disease risk in epidemiologic studies The American Journal of Clinical Nutrition 81 2005 317 325
130. S.C. Thomasset, D.P. Berry, G. Garcea, T. Marczylo, W.P. Steward, and A.J. Gescher Dietary polyphenolic phytochemicals-promising cancer chemopreventive agents in humans? A review of their clinical properties International Journal of Cancer 120 2007 451 458 (Pubitemid 44969013)
131. R.W. deVere White, R.M. Hackman, S.E. Soares, L.A. Beckett, Y. Li, and B. Sun Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer Urology 63 2004 259 263 (Pubitemid 38234414)
132. N. Miyanaga, H. Akaza, and S. Hinotsu Prostate cancer chemoprevention study: an investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen Cancer Science 103 2012 125 130
133. H. Ide, S. Tokiwa, and K. Sakamaki Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen Prostate 70 2010 1127 1133
134. S. Bettuzzi, M. Brausi, F. Rizzi, G. Castagnetti, G. Peracchia, and A. Corti Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study Cancer Research 66 2006 1234 1240 (Pubitemid 43165995)
135. M.M. Nguyen, F.R. Ahmann, and R.B. Nagle Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities Cancer Prevention Research 5 2012 290 298
136. H. Hoensch, B. Groh, L. Edler, and W. Kirch Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence World Journal of Gastroenterology 14 2008 2187 2193
137. M. Shimizu, Y. Fukutomi, and M. Ninomiya Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 17 2008 3020 3025
138. K.R. Patel, V.A. Brown, and D.J. Jones Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients Cancer Research 70 2010 7392 7399
139. N. Dhillon, B.B. Aggarwal, and R.A. Newman Phase II trial of curcumin in patients with advanced pancreatic cancer Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14 2008 4491 4499
140. J.C. Stingl, T. Ettrich, and R. Muche Protocol for minimizing the risk of metachronous adenomas of the CoLorectum with Green Tea Extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population BMC Cancer 11 2011 360
141. A. Vidlar, J. Vostalova, and J. Ulrichova The safety and efficacy of a silymarin and selenium combination in men after radical prostatectomy - a six month placebo-controlled double-blind clinical trial Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 154 2010 239 244
142. J. Tomé-Carneiro, M. Gonzálvez, and M. Larrosa Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial Molecular Nutrition & Food Research 56 2012 810 821
143. J. Tomé-Carneiro, M. Gonzálvez, and M. Larrosa One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease The American Journal of Cardiology 110 2012 356 363
144. J. Tomé-Carneiro, M. Gonzálvez, and M. Larrosa Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease Cardiovascular Drugs and Therapy 27 2013 37 48
145. J. Tomé-Carneiro, M. Larrosa, and M.J. Yáñez- Gascón One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease Pharmacological Research: the Official Journal of the Italian Pharmacological Society 72 2013 69 82
146. J.P. Crandall, V. Oram, and G. Trandafirescu Pilot study of resveratrol in older adults with impaired glucose tolerance The Journals of Gerontology. Series A. Biological Sciences and Medical Sciences 67 2012 1307 1312
147. I. Alwi, T. Santoso, and S. Suyono The effect of curcumin on lipid level in patients with acute coronary syndrome Acta Medica Indonesiana 40 2008 201 210
148. R. Miyazaki, K. Kotani, and M. Ayabe Minor effects of green tea catechin supplementation on cardiovascular risk markers in active older people: a randomized controlled trial Geriatrics & Gerontology International 2012 10.1111/j.1447-0594.2012.00952.x
149. T. Mackenzie, L. Leary, and W.B. Brooks The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study Metabolism 56 2007 1340 1344 (Pubitemid 47404595)
150. P. Kar, D. Laight, H.K. Rooprai, K.M. Shaw, and M. Cummings Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity Diabetic Medicine: A Journal of the British Diabetic Association 26 2009 526 531
151. M. Velussi, A.M. Cernigoi, A. De Monte, F. Dapas, C. Caffau, and M. Zilli Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients Journal of Hepatology 26 1997 871 879 (Pubitemid 27145712)
152. V. Jayagopal, P. Albertazzi, and E.S. Kilpatrick Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes Diabetes Care 25 2002 1709 1714 (Pubitemid 41071075)
153. A.H. Wu, D. Spicer, F.Z. Stanczyk, C.C. Tseng, C.S. Yang, and M.C. Pike Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women Cancer Prevention Research 5 2012 393 402
154. D. Kritz-Silverstein, D. Von Mühlen, E. Barrett-Connor, and M.A. Bressel Isoflavones and cognitive function in older women: the SOy and postmenopausal health in aging (SOPHIA) study Menopause 10 2003 196 202 (Pubitemid 36706302)
155. J.B. Howes, K. Bray, L. Lorenz, P. Smerdely, and L.G. Howes The effects of dietary supplementation with isoflavones from red clover on cognitive function in postmenopausal women Climacteric 7 2004 70 77 (Pubitemid 38367165)
156. S. Kreijkamp-Kaspers, L. Kok, and D.E. Grobbee Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial JAMA: the Journal of the American Medical Association 292 2004 65 74 (Pubitemid 38923795)
157. S.C. Ho, A.S. Chan, and Y.P. Ho Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial Menopause 14 2007 489 499
158. V.W. Henderson, J.A. St John, and H.N. Hodis Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial Neurology 78 2012 1841 1848
159. R. Duffy, H. Wiseman, and S.E. File Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones Pharmacology, Biochemistry, and Behavior 75 2003 721 729 (Pubitemid 36936904)
160. J.A. Joseph, B. Shukitt-Hale, and L.M. Willis Grape juice, berries, and walnuts affect brain aging and behavior The Journal of Nutrition 139 2009 1813S 1817S
161. M.P. Pase, A.B. Scholey, and A. Pipingas Cocoa polyphenols enhance positive mood states but not cognitive performance: a randomized, placebo-controlled trial Journal of Psychopharmacology 27 2013 451 458
162. N.S. Werner, S. Duschek, and R. Schandry D-camphor-crataegus berry extract combination increases blood pressure and cognitive functioning in the elderly - a randomized, placebo controlled double blind study Phytomedicine 16 2009 1077 1082
163. S.K. Park, I.C. Jung, and W.K. Lee A combination of green tea extract and l-theanine improves memory and attention in subjects with mild cognitive impairment: a double-blind placebo-controlled study Journal of Medicinal Food 14 2011 334 343
164. K. Taku, M.K. Melby, N. Nishi, T. Omori, and M.S. Kurzer Soy isoflavones for osteoporosis: an evidence-based approach Maturitas 70 2011 333 338
165. P. Wei, M. Liu, Y. Chen, and D.C. Chen Systematic review of soy isoflavone supplements on osteoporosis in women Asian Pacific Journal of Tropical Medicine 5 2012 243 248
166. B. Falsini, D. Marangoni, and T. Salgarello Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram Graefe's Archive for Clinical and Experimental Ophthalmology 247 2009 1223 1233
167. H. Ohguro, I. Ohguro, M. Katai, and S. Tanaka Two-year randomized, placebo-controlled study of black currant anthocyanins on visual field in glaucoma Ophthalmologica 228 2012 26 35
168. H. Ohguro, I. Ohguro, and S. Yagi Effects of black currant anthocyanins on intraocular pressure in healthy volunteers and patients with glaucoma Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 29 2013 61 67
169. K. Yoshida, I. Ohguro, and H. Ohguro Black currant anthocyanins normalized abnormal levels of serum concentrations of Endothelin-1 in patients with glaucoma Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 2012 10.1089/jop.2012.0198
170. T. Tanaka, M. Shnimizu, and H. Moriwaki Cancer chemoprevention by carotenoids Molecules 17 2012 3202 3242
171. B. Olmedilla, F. Granado, I. Blanco, and M. Vaquero Lutein, but not alpha-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study Nutrition 19 2003 21 24 (Pubitemid 36044481)
172. S. Richer, W. Stiles, and L. Statkute Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial) Optometry 75 2004 216 230 (Pubitemid 39208022)
173. L. Ma, H.L. Dou, and Y.M. Huang Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial American Journal of Ophthalmology 154 2012 625 634
174. L. Ma, S.F. Yan, and Y.M. Huang Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration Ophthalmology 119 2012 2290 2297
175. Y.M. Huang, S.F. Yan, and L. Ma Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration Nutrition 29 2013 387 392
176. G. Weigert, S. Kaya, and B. Pemp Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration Investigative Ophthalmology & Visual Science 52 2011 8174 8178
177. P. Bucheli, K. Vidal, and L. Shen Goji berry effects on macular characteristics and plasma antioxidant levels Optometry and Vision Science: Official Publication of the American Academy of Optometry 88 2011 257 262
178. H.E. Bartlett, and F. Eperjesi Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-relatedmacular disease: a randomized controlled trial European Journal of Clinical Nutrition 61 2007 1121 1127 (Pubitemid 47386599)
179. Y. Sasamoto, F. Gomi, M. Sawa, M. Tsujikawa, and K. Nishida Effect of 1-year lutein supplementation on macular pigment optical density and visual function Graefe's Archive for Clinical and Experimental Ophthalmology 249 2011 1847 1854
180. E.J. Berrow, H.E. Bartlett, F. Eperjesi, and J.M. Gibson The effects of a lutein-based supplement on objective and subjective measures of retinal and visual function in eyes with age-related maculopathy - a randomised controlled trial The British Journal of Nutrition Oct 2012 1 7 10.1017/S0007114512004187
181. E.C. Von Löw, F.G. Perabo, R. Siener, and S.C. Müller Review. Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data In Vivo (Athens, Greece) 21 2007 189 204
182. S. Schwarz, U.C. Obermüller-Jevic, E. Hellmis, W. Koch, G. Jacobi, and H.K. Biesalski Lycopene inhibits disease progression in patients with benign prostate hyperplasia The Journal of Nutrition 138 2008 49 53
183. C. Schwenke, B. Ubrig, P. Thürmann, C. Eggersmann, and S. Roth Lycopene for advanced hormone refractory prostate cancer: a prospective, open phase II pilot study The Journal of Urology 181 2009 1098 1103
184. A. Vrieling, D.W. Voskuil, and J.M. Bonfrer Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer The American Journal of Clinical Nutrition 86 2007 1456 1462 (Pubitemid 350126251)
185. G. Riccioni, L. Scotti, and E. Di Ilio Lycopene and preclinical carotid atherosclerosis Journal of Biological Regulators and Homeostatic Agents 25 2011 435 441
186. L.S. Kim, L.J. Axelrod, P. Howard, N. Buratovich, and R.F. Waters Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 14 2006 286 294 (Pubitemid 43329539)
187. E.M. Debbi, G. Agar, and G. Fichman Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study BMC Complementary and Alternative Medicine 11 2011 50
188. P.R. Usha, and M.U. Naidu Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis Clinical Drug Investigation 24 2004 353 363 (Pubitemid 38858258)
189. S. Devaraj, and I. Jialal The role of dietary supplementation with plant sterols and stanols in the prevention of cardiovascular disease Nutrition Reviews 64 2006 348 354 (Pubitemid 44124979)
190. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific opinion on the substantiation of a health claim related to 3 g/day plant sterols/stanols and lowering blood LDL-cholesterol and reduced risk of (coronary) heart disease pursuant to Article 19 of Regulation (EC) No 1924/2006 EFSA Journal 10 5 2012 2693 [13 pp.]
191. Anon. A report from the data collection and exposure unit in response to a request from the European Commission. Consumption of food and beverages with added plant sterols in the European Union The EFSA Journal 133 2008 1 21
192. B. Genser, G. Silbernagel, and G. De Backer Plant sterols and cardiovascular disease: a systematic review and meta-analysis European Heart Journal 33 2012 444 451
193. O. Weingärtner, M. Böhm, and U. Laufs Controversial role of plant sterol esters in the management of hypercholesterolaemia European Heart Journal 30 2009 404 409
194. D. Woodgate, C.H. Chan, and J.A. Conquer Cholesterol-lowering ability of a phytostanol softgel supplement in adults with mild to moderate hypercholesterolemia Lipids 41 2006 127 132
195. A.C. Goldberg, R.E. Ostlund Jr., J.H. Bateman, L. Schimmoeller, T.B. McPherson, and C.A. Spilburg Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs The American Journal of Cardiology 97 2006 376 379 (Pubitemid 43133053)
196. N. Volpi Analytical aspects of pharmaceutical grade chondroitin sulfates Journal of Pharmaceutical Sciences 96 2007 3168 3180
197. C. Black, C. Clar, and R. Henderson The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation Health Technology Assessment 13 2009 1 148
198. I. Setnikar, and L.C. Rovati Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review Arzneimittelforschung 51 2001 699 725 (Pubitemid 32889393)
199. S. Persiani, R. Rotini, and G. Trisolino Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 15 2007 764 772 (Pubitemid 46888164)
200. F. Ronca, L. Palmieri, P. Panicucci, and G. Ronca Anti-inflammatory activity of chondroitin sulfate Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 6 1998 14 21 (Pubitemid 28255099)
201. N. Volpi Oral absorption and bioavailability of ichthyic origin chondroitin sulfate in healthy male volunteers Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 11 2003 433 441 (Pubitemid 36722657)
202. W. Zhang, G. Nuki, and R.W. Moskowitz OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009 Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 18 2010 476 499
203. M.C. Hochberg, M. Zhan, and P. Langenberg The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate Current Medical Research and Opinion 24 2008 3029 3035
204. T.E. McAlindon, M.P. LaValley, J.P. Gulin, and D.T. Felson Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis JAMA: the Journal of the American Medical Association 283 2000 1469 1475 (Pubitemid 30151826)
205. J.M. Bjordal, A. Klovning, A.E. Ljunggren, and L. Slørdal Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials European Journal of Pain (London, England) 11 2007 125 138 (Pubitemid 44829965)
206. C.G. Jackson, A.H. Plaas, and J.D. Sandy The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 18 2010 297 302
207. J.P. Van Vijven, P.A. Luijsterburg, A.P. Verhagen, G.J. van Osch, M. Kloppenburg, and S.M. Bierma-Zeinstra Symptomatic and chondroprotective treatment with collagen derivatives in osteoarthritis: a systematic review Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 20 2012 809 821
208. T.E. McAlindon, M. Nuite, and N. Krishnan Change in knee osteoarthritis cartilage detected by delayed gadolinium enhanced magnetic resonance imaging following treatment with collagen hydrolysate: a pilot randomized controlled trial Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 19 2011 399 405
209. A.G. Schauss, J. Stenehjem, J. Park, J.R. Endres, and A. Clewell Effect of the novel low molecular weight hydrolyzed chicken sternal cartilage extract, BioCell Collagen, on improving osteoarthritis-related symptoms: a randomized, double-blind, placebo-controlled trial Journal of Agricultural and Food Chemistry 60 2012 4096 4101
210. G. Batist, F. Patenaude, and P. Champagne Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels Annals of Oncology: Official Journal of the European Society for Medical Oncology 13 2002 1259 1263 (Pubitemid 34960135)
211. C. Lu, J.J. Lee, and R. Komaki Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial Journal of the National Cancer Institute 102 2010 859 865
212. C.L. Loprinzi, R. Levitt, and D.L. Barton Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group Trial Cancer 104 2005 176 182 (Pubitemid 40847766)
213. M.A. Karsdal, K. Henriksen, and A.C. Bay-Jensen Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials Journal of Clinical Pharmacology 51 2011 460 471
214. L.B. Tankó, Y.Z. Bagger, and P. Alexandersen Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 19 2004 1531 1538 (Pubitemid 41094356)
215. Y.Z. Bagger, L.B. Tankó, and P. Alexandersen Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis Bone 37 2005 425 430 (Pubitemid 41160502)
216. D.H. Manicourt, M. Azria, L. Mindeholm, E.J. Thonar, and J.P. Devogelaer Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis Arthritis and Rheumatism 54 2006 3205 3211 (Pubitemid 44622091)
217. M.A. Karsdal, I. Byrjalsen, A.C. Bay-Jensen, K. Henriksen, B.J. Riis, and C. Christiansen Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis - the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation BMC Musculoskeletal Disorders 11 2010 125
218. M.A. Karsdal, I. Byrjalsen, D.J. Leeming, P.D. Delmas, and C. Christiansen The effects of oral calcitonin on bone collagen maturation: implications for bone turnover and quality Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 19 2008 1355 1361
219. M.A. Karsdal, I. Byrjalsen, and K. Henriksen The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 18 2010 150 159
220. N. Binkley, M. Bolognese, and A. Sidorowicz-Bialynicka A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 27 2012 1821 1829
221. Study to evaluate oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D. ClinicalTrials.gov Identifier: NCT00525798.
222. Efficacy and safety of oral salmon calcitonin in patients with knee osteoarthritis (OA 2 Study). ClinicalTrials.gov Identifier: NCT00704847.
223. Calcitonin Salmon for the Treatment of Postmenopausal Osteoporosis. Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee. http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ ReproductiveHealthDrugsAdvisoryCommittee/UCM343748.pdf.
224. M. Iriti, E.M. Varoni, and S. Vitalini Melatonin in traditional Mediterranean diets Journal of Pineal Research 49 2010 101 105
225. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, J.J. Sanchez-Sanchez, J.C. Kaski, and R.J. Reiter Melatonin and circadian biology in human cardiovascular disease Journal of Pineal Research 49 2010 14 22
226. J.S. Peck, D.B. LeGoff, I. Ahmed, and D. Goebert Cognitive effects of exogenous melatonin administration in elderly persons: a pilot study The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry 12 2004 432 436 (Pubitemid 38878863)
227. M. Rondanelli, A. Opizzi, and M. Faliva Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment Nutritional Neuroscience 15 2012 46 54
228. S. Otmani, A. Demazières, and C. Staner Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers Human Psychopharmacology 23 2008 693 705
229. E.J. Sánchez-Barceló, M.D. Mediavilla, D.X. Tan, and R.J. Reiter Clinical uses of melatonin: evaluation of human trials Current Medicinal Chemistry 17 2010 2070 2095
230. C. Yi, X. Pan, H. Yan, M. Guo, and W. Pierpaoli Effects of melatonin in age-related macular degeneration Annals of the New York Academy of Sciences 1057 2005 384 392 (Pubitemid 43211648)
231. F. Brivio, L. Fumagalli, and G. Fumagalli Synchronization of cortisol circadian rhythm by the pineal hormone melatonin in untreatable metastatic solid tumor patients and its possible prognostic significance on tumor progression In Vivo (Athens, Greece) 24 2010 239 241
232. P. Lissoni, F. Brivio, and L. Fumagalli Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors Anticancer Research 28 2008 1377 1381 (Pubitemid 351578883)
233. G. Cerea, M. Vaghi, and A. Ardizzoia Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil- containing combinations Anticancer Research 23 2003 1951 1954 (Pubitemid 36750873)
234. E. Grossman, M. Laudon, and R. Yalcin Melatonin reduces night blood pressure in patients with nocturnal hypertension The American Journal of Medicine 119 2006 898 902 (Pubitemid 44415610)
235. G. López-Lluch, J.C. Rodríguez-Aguilera, C. Santos-Ocaña, and P. Navas Is coenzyme Q a key factor in aging? Mechanisms of Ageing and Development 131 2010 225 235
236. R. Laaksonen, M. Fogelholm, J.J. Himberg, J. Laakso, and Y. Salorinne Ubiquinone supplementation and exercise capacity in trained young and older men European Journal of Applied Physiology and Occupational Physiology 72 1995 95 100 (Pubitemid 26004025)
237. K. Kȩdziora-Kornatowska, J. Czuczejko, and J. Motyl Effects of coenzyme Q10 supplementation on activities of selected antioxidative enzymes and lipid peroxidation in hypertensive patients treated with indapamide. A pilot study Archives of Medicinal Science 6 2010 513 518
238. E.M. Yubero-Serrano, N. Delgado-Casado, and J. Delgado-Lista Postprandial antioxidant effect of the Mediterranean diet supplemented with coenzyme Q10 in elderly men and women Age 33 2011 579 590
239. E.M. Yubero-Serrano, L. Gonzalez-Guardia, and O. Rangel-Zuñiga Mediterranean diet supplemented with coenzyme Q10 modifies the expression of proinflammatory and endoplasmic reticulum stress-related genes in elderly men and women The Journals of Gerontology. Series A. Biological Sciences and Medical Sciences 67 2012 3 10
240. B.J. Lee, Y.C. Huang, S.J. Chen, and P.T. Lin Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease Nutrition 28 2012 767 772
241. B.J. Lee, Y.C. Huang, S.J. Chen, and P.T. Lin Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease Nutrition 28 2012 250 255
242. Y.L. Dai, T.H. Luk, and K.H. Yiu Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial Atherosclerosis 216 2011 395 401
243. S. Sander, C.I. Coleman, A.A. Patel, J. Kluger, and C.M. White The impact of coenzyme Q10 on systolic function in patients with chronic heart failure Journal of Cardiac Failure 12 2006 464 472 (Pubitemid 46106977)
244. S. Pepe, J.Y. Leong, and J. Van der Merwe Targeting oxidative stress in surgery: effects of ageing and therapy Experimental Gerontology 43 2008 653 657
245. J.Y. Leong, J. van der Merwe, and S. Pepe Perioperative metabolic therapy improves redox status and outcomes in cardiac surgery patients: a randomised trial Heart, Lung & Circulation 19 2010 584 591
246. N. Naidoo, R.M. van Dam, and W.P. Koh Plasma vitamin E and coenzyme Q10 are not associated with a lower risk of acute myocardial infarction in Singapore Chinese adults The Journal of Nutrition 142 2012 1046 1052
247. C. Borek Anti-aging effects of coenzyme Q10 Agro Food Industry Hi-Tech 15 2004 24 26
248. D.A. Bookstaver, N.A. Burkhalter, and C. Hatzigeorgiou Effect of coenzyme Q10 supplementation on statin-induced myalgias The American Journal of Cardiology 110 2012 526 529
249. B.P. Forester, C.S. Zuo, and C. Ravichandran Coenzyme Q10 effects on creatine kinase activity and mood in geriatric bipolar depression Journal of Geriatric Psychiatry and Neurology 25 2012 43 50
250. J.J. Chen Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment The American Journal of Managed Care 16 2010 S87 S93
251. D.R. Galasko, E. Peskind, and C.M. Clark Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures Archives of Neurology 69 2012 836 841
252. Anon. Scientific Opinion on the substantiation of health claims related to coenzyme Q10 and contribution to normal energy-yielding metabolism (ID 1508, 1512, 1720, 1912, 4668), maintenance of normal blood pressure (ID 1509, 1721, 1911), protection of DNA, proteins and lipids from oxidative damage (ID 1510), contribution to normal cognitive function (ID 1511), maintenance of normal blood cholesterol concentrations (ID 1721) and increase in endurance capacity and/or endurance performance (ID 1913) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 The EFSA Journal 8 10 2010 1793
253. Institute of Medicine (IOM) Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline 1998 National Academies Press Washington, DC
254. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of health claims related to choline and contribution to normal lipid metabolism (ID 3186), maintenance of normal liver function (ID 1501), contribution to normal homocystein e metabolism (ID 3090), maintenance of normal neurological function (ID 1502), contribution to normal cognitive function (ID 1502), and brain and neurological development (ID 1503) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Journal 9 4 2011 2056 [23 pp.]
255. M. Aktas, M. Wessel, S. Hacker, S. Klusener, J. Gleichenhagen, and F. Narberhaus Phosphatidylcholine biosynthesis and its significance in bacteria interacting with eukaryotic cells European Journal of Cell Biology 89 2010 888 894
256. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of health claims related to soy phosphatidylcholine and maintenance of normal blood cholesterol concentrations (ID 709, 1308, 1630, 1961, 3138, 3187, 4687), contribution to normal fat metabolism (ID 1597), increase in the intestinal absorption of glutamine (ID 4251), faster recovery from muscle fatigue after exercise (ID 4249), improvement of neuromuscular function (ID 4250), contribution to normal cognitive function (ID 710, 1596, 1631, 1983) and maintenance of normal neurological function (ID 1596) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Journal 8 10 2010 1741 [26 pp.]
257. T. Cenacchi, T. Bertoldin, C. Farina, M.G. Fiori, and G. Crepaldi Cognitive decline in the elderly: a double-blind, placebocontrolled multicenter study on efficacy of phosphatidylserine administration Aging Clinical and Experimental Research 5 1993 123 133 (Pubitemid 23148315)
258. L. Amaducci the SMID group Phosphatidylserine in the treatment of Alzheimer's disease: results of a multicenter study Psychopharmacology Bulletin 24 1998 130 134
259. T. Crook, W. Petrie, C. Wells, and D.C. Massari Effects of phosphatidylserine in Alzheimer's disease Psychopharmacology Bulletin 28 1992 61 66
260. R.R. Engel, W. Satzger, and W. Günther Double-blind cross-over study of phosphatidyl-serine vs. placebo in patients with early dementia of Alzheimer type European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 2 1992 149 155
261. E.W. Funfgeld, M. Baggen, P. Nedwidek, B. Richstein, and G. Mistlberger Double-blind study with phosphatidylserine (PS) in Parkinsonian patients with senile dementia of Alzheimer's type (SDAT) Progress in Clinical and Biological Research 317 1989 1235 1246
262. G. Palmieri, R. Palmieri, and M.R. Inzoli Double-blind controlled trial of phosphatidylserine in patients with senile mental deterioration Clinical Trials Journal 24 1987 73 83 (Pubitemid 17074085)
263. A. Kato-Kataoka, M. Sakai, R. Ebina, C. Nonaka, T. Asano, and T. Miyamori Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints Journal of Clinical Biochemistry Nutrition 47 2010 246 255
264. B.L. Jorissen, F. Brouns, and M.P. Van Boxtel The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment Nutritional Neuroscience 4 2001 121 134 (Pubitemid 34071732)
265. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of health claims related to phosphatidyl serine (ID 552, 711, 734, 1632, 1927) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Journal 8 10 2010 1749 [15 pp.]
266. S.A. Craig Betaine in human nutrition The American Journal of Clinical Nutrition 80 2004 539 549 (Pubitemid 41115516)
267. M. Lever, P.M. George, and W. Atkinson Plasma lipids and betaine are related in an acute coronary syndrome cohort PLoS One 6 2011 e21666
268. D.O. McGregor, W.J. Dellow, R.A. Robson, M. Lever, P.M. George, and S.T. Chambers Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure Kidney International 61 2002 1040 1046 (Pubitemid 34175473)
269. Anon. Scientific Opinion on the substantiation of health claims related to betaine and contribution to normal homocysteine metabolism (ID 4325) pursuant to Article 13(1) of Regulation (EC) No 1924/20061 EFSA Journal 9 2011 2052
270. H.R. Maurer Bromelain: biochemistry, pharmacology and medical use Cellular and Molecular Life Sciences: CMLS 58 2001 1234 1245 (Pubitemid 32850918)
271. K. Chobotova, A.B. Vernallis, and F.A. Majid Bromelain's activity and potential as an anti-cancer agent: current evidence and perspectives Cancer Letters 290 2010 148 156
272. A.F. Walker, R. Bundy, S.M. Hicks, and R.W. Middleton Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults Phytomedicine 9 2002 681 686 (Pubitemid 36152125)
273. S. Brien, G. Lewith, A.F. Walker, R. Middleton, P. Prescott, and R. Bundy Bromelain as an adjunctive treatment for moderate-to-severe osteoarthritis of the knee: a randomized placebo-controlled pilot study QJM: Monthly Journal of the Association of Physicians 99 2006 841 850 (Pubitemid 46024095)
274. J. Liu, J. Zhang, Y. Shi, S. Grimsgaard, T. Alraek, and V. Fonnebo Chinese red yeast rice (monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials Chinese Medical Journal 1 2006 4
275. S.P. Zhao, Z.L. Lu, and B.M. Du Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS) Journal of Cardiovascular Pharmacology 49 2007 81 84
276. M.P. Bogsrud, L. Ose, and G. Langslet HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study Scandinavian Cardiovascular Journal: SCJ 44 2010 197 200
277. D.J. Becker, R.Y. Gordon, S.C. Halbert, B. French, P.B. Morris, and D.J. Rader Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial Annals of Internal Medicine 150 2009 830 839
278. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of health claims related to monacolin K from red yeast rice and maintenance of normal blood LDL-cholesterol concentrations (ID 1648, 1700) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Journal 9 7 2011 2304 [16 pp.]
279. Z. Lu, W. Kou, and B. Du Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction The American Journal of Cardiology 101 2008 1689 1693
280. S.P. Zhao, L. Liu, Y.C. Cheng, and Y.L. Li Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease Atherosclerosis 168 2003 375 380 (Pubitemid 36703337)
281. S.P. Zhao, L. Liu, and Y.C. Cheng Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease Circulation 110 2004 915 920 (Pubitemid 39128616)
282. V. Kuptniratsaikul, S. Thanakhumtorn, P. Chinswangwatanakul, L. Wattanamongkonsil, and V. Thamlikitkul Efficacy and safety of Curcuma domestica extracts in patients with knee osteoarthritis Journal of Alternative and Complementary Medicine 15 2009 891 897
283. N. Kertia, A.H. Asdie, W. Rochmah, and Marsetyawan Ability of curcuminoid compared to diclofenac sodium in reducing the secretion of cycloxygenase-2 enzyme by synovial fluid's monocytes of patients with osteoarthritis Acta Medica Indonesiana 44 2012 105 113
284. R. Christensen, E.M. Bartels, R.D. Altman, A. Astrup, and H. Bliddal Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients? A meta-analysis of randomized controlled trials Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 16 2008 965 972
285. S.N. Willich, K. Rossnagel, and S. Roll Rose hip herbal remedy in patients with rheumatoid arthritis - a randomised controlled trial Phytomedicine 17 2010 87 93
286. B. Kirkeskov, R. Christensen, and S. Bügel The effects of rose hip (Rosa canina) on plasma antioxidative activity and C-reactive protein in patients with rheumatoid arthritis and normal controls: a prospective cohort study Phytomedicine 18 2011 953 958
287. R.D. Altman, and K.C. Marcussen Effects of a ginger extract on knee pain in patients with osteoarthritis Arthritis and Rheumatism 44 2001 2531 2538 (Pubitemid 33049331)
288. H. Bliddal, A. Rosetzsky, and P. Schlichting A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 8 2000 9 12 (Pubitemid 30032721)
289. M. Haghighi, A. Khalva, T. Toliat, and S. Jallaei Comparing the effects of ginger (Zingiber officinale) extract and ibuprofen on patients with osteoarthritis Archives of Iranian Medicine 8 2005 267 271 (Pubitemid 41535796)
290. I. Wigler, I. Grotto, D. Caspi, and M. Yaron The effects of Zintona EC (a ginger extract) on symptomatic gonarthritis Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 11 2003 783 789 (Pubitemid 37407594)
291. K. Ried, O.R. Frank, and N.P. Stocks Aged garlic extract reduces blood pressure in hypertensives: a dose-response trial European Journal of Clinical Nutrition 67 2013 64 70
292. K.M. Reinhart, C.I. Coleman, C. Teevan, P. Vachhani, and C.M. White Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis The Annals of Pharmacotherapy 42 2008 1766 1771
293. K. Ried, O.R. Frank, N.P. Stocks, P. Fakler, and T. Sullivan Effect of garlic on blood pressure: a systematic review and meta-analysis BMC Cardiovascular Disorders 8 2008 13
294. K. Ried, O.R. Frank, and N.P. Stocks Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: a randomised controlled trial Maturitas 67 2010 144 150
295. H. Ishikawa, T. Saeki, and T. Otani Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer The Journal of Nutrition 136 2006 816S 820S (Pubitemid 43363784)
296. T. Wakimoto, H. Kondo, and H. Nii Furan fatty acid as an anti-inflammatory component from the green-lipped mussel Perna canaliculus Proceedings of the National Academy of Sciences of the United States of America 108 2011 17533 17537
297. S.A. Doggrell Lyprinol-is it a useful anti-inflammatory agent? Evidence-Based Complementary and Alternative Medicine 2011 2011 307121
298. F. Blotman, E. Maheu, A. Wulwik, H. Caspard, and A. Lopez Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial Rev Rhum Engl Ed 64 1997 825 834 (Pubitemid 28078795)
299. T. Appelboom, J. Schuermans, G. Verbruggen, Y. Henrotin, and J.Y. Reginster Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo-controlled study Scandinavian Journal of Rheumatology 30 2001 242 247 (Pubitemid 32762863)
300. K. Pavelka, P. Coste, P. Géher, and G. Krejci Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee Clinical Rheumatology 29 2010 659 670
301. E. Maheu, C. Cadet, and M. Marty Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study Annals of the Rheumatic Diseases 2013 10.1136/annrheumdis-2012-202485
302. M. Lequesne, E. Maheu, C. Cadet, and R.L. Dreiser Structural effect of avocado/soybean unsaponifiables on joint space loss in osteoarthritis of the hip Arthritis and Rheumatism 47 2002 50 58 (Pubitemid 34137344)
303. R. Christensen, E.M. Bartels, A. Astrup, and H. Bliddal Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 16 2008 399 408 (Pubitemid 351426276)
304. P. Olivier, and J.L. Montastruc Réseau français des centres régionaux de pharmacovigilance. Post-marketing safety profile of avocado-soybean unsaponifiables Presse Medicale 39 2010 e211 e216
305. B. Mang, M. Wolters, and B. Schmitt Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2 European Journal of Clinical Investigation 36 2006 340 344
306. T. Lu, H. Sheng, J. Wu, Y. Cheng, J. Zhu, and Y. Chen Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes Nutrition Research 32 2012 408 412
307. N.M. Berry, M.J. Robinson, J. Bryan, J.D. Buckley, K.J. Murphy, and P.R. Howe Acute effects of an Avena sativa herb extract on responses to the Stroop Color-Word test Journal of Alternative and Complementary Medicine 17 2011 635 637
308. R.H. Wong, P.R. Howe, J. Bryan, A.M. Coates, J.D. Buckley, and N.M. Berry Chronic effects of a wild green oat extract supplementation on cognitive performance in older adults: a randomised, double-blind, placebo-controlled, crossover trial Nutrients 4 2012 331 342
309. S. Akhondzadeh, M. Noroozian, M. Mohammadi, S. Ohadinia, A.H. Jamshidi, and M. Khani Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial Journal of Clinical Pharmacy and Therapeutics 28 2003 53 59 (Pubitemid 36313176)
310. A.B. Scholey, N.T. Tildesley, and C.G. Ballard An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers Psychopharmacology 198 2008 127 139
311. S. Akhondzadeh, M. Shafiee Sabet, and M.H. Harirchian A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease Psychopharmacology 207 2010 637 643
312. A. Pengelly, J. Snow, S.Y. Mills, A. Scholey, K. Wesnes, and L.R. Butler Short-term study on the effects of rosemary on cognitive function in an elderly population Journal of Medicinal Food 15 2012 10 17